Last reviewed · How we verify

NCT05420155: SURGHIDA

Surgical Treatment of Liver Hydatid Cyst (SURGHIDA)

Completed Last updated 15 June 2022
What this trial tests

trial testing Surgical resection in Echinococcosis, Hepatic in 296 participants. Completed in 30 May 2022.

Timeline
1 January 2006
Primary endpoint
31 December 2021
30 May 2022

Quick facts

Lead sponsorUniversidad de Extremadura
StatusCompleted
Study typeOBSERVATIONAL
Enrollment296
Start date1 January 2006
Primary completion31 December 2021
Estimated completion30 May 2022

Drugs / interventions tested

Conditions studied

Sponsor

Universidad de Extremadura

Who can join

18 and older, any sex, with Echinococcosis, Hepatic. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim was to analyses the incidence and the independent factors associated with Textbook Outcome following surgical treatment of liver hydatid cysts (LHC).

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Surgical resection

Trials testing the same drug.

Other recruiting trials for Echinococcosis, Hepatic

Currently open trials in the same condition.

Other Universidad de Extremadura trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05420155.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing